The small GTPases K-Ras, N-Ras, and H-Ras have distinct biochemical properties determined by allosteric effects

被引:95
|
作者
Johnson, Christian W. [1 ]
Reid, Derion [1 ]
Parker, Jillian A. [1 ]
Salter, Shores [1 ]
Knihtila, Ryan [1 ]
Kuzmic, Petr [2 ]
Mattos, Carla [1 ]
机构
[1] Northeastern Univ, Dept Chem & Chem Biol, 102 Hurtig Hall,360 Huntington Ave, Boston, MA 02115 USA
[2] BioKin Ltd, Watertown, MA 02472 USA
基金
美国国家科学基金会;
关键词
allosteric regulation; conformational change; enzyme catalysis; enzyme structure; oncogene; Ras protein; ACTIVATING PROTEINS; GTP HYDROLYSIS; CONFORMATIONAL STATES; EVOLUTIONARY TREE; ESCHERICHIA-COLI; STRUCTURAL BASIS; NUCLEOTIDE-FREE; P21; EXPRESSION; PHOSPHATE;
D O I
10.1074/jbc.M117.778886
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
H-Ras, K-Ras, and N-Ras are small GTPases that are important in the control of cell proliferation, differentiation, and survival, and their mutants occur frequently in human cancers. The G-domain, which catalyzes GTP hydrolysis and mediates downstream signaling, is 95% conserved between the Ras isoforms. Because of their very high sequence identity, biochemical studies done on H-Ras have been considered representative of all three Ras proteins. We show here that this is not a valid assumption. Using enzyme kinetic assays under identical conditions, we observed clear differences between the three isoforms in intrinsic catalysis of GTP by Ras in the absence and presence of the Ras-binding domain (RBD) of the c-Raf kinase protein (Raf-RBD). Given their identical active sites, isoform G-domain differences must be allosteric in origin, due to remote isoform-specific residues that affect conformational states. We present the crystal structure of N-Ras bound to a GTP analogue and interpret the kinetic data in terms of structural features specific for H-, K-, and N-Ras.
引用
收藏
页码:12981 / 12993
页数:13
相关论文
共 50 条
  • [1] N-RAS, H-RAS, AND K-RAS - A DIFFERENCE IN TRANSFORMING POTENTIAL
    MAHER, J
    BAKER, DA
    DIBB, NJ
    ROBERTS, IAG
    BLOOD, 1994, 84 (10) : A295 - A295
  • [2] H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers
    Przybojewska, B
    Jagiello, A
    Jalmuzna, P
    CANCER GENETICS AND CYTOGENETICS, 2000, 121 (01) : 73 - 77
  • [3] EVIDENCE FOR CELL-SPECIFIC DIFFERENCES IN TRANSFORMATION BY N-RAS, H-RAS AND K-RAS
    MAHER, J
    BAKER, DA
    MANNING, M
    DIBB, NJ
    ROBERTS, IAG
    ONCOGENE, 1995, 11 (08) : 1639 - 1647
  • [4] ANALYSIS OF H-RAS, K-RAS AND N-RAS GENES FOR EXPRESSION, MUTATION AND AMPLIFICATION IN LARYNGEAL TUMORS
    KIARIS, H
    SPANDIDOS, DA
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (01) : 75 - 80
  • [5] Analysis of K-ras, N-ras, H-ras, and p53 in lung neuroendocrine neoplasms
    Couce, ME
    Bautista, D
    Costa, J
    Carter, D
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1999, 8 (02) : 71 - 79
  • [6] Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients
    Malgorzata Banys-Paluchowski
    Karin Milde-Langosch
    Tanja Fehm
    Isabell Witzel
    Leticia Oliveira-Ferrer
    Barbara Schmalfeldt
    Volkmar Müller
    Breast Cancer Research and Treatment, 2020, 179 : 403 - 414
  • [7] Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors
    Vageli, D
    Kiaris, H
    Delakas, D
    Anezinis, P
    Cranidis, A
    Spandidos, DA
    CANCER LETTERS, 1996, 107 (02) : 241 - 247
  • [8] The K-Ras, N-Ras, and H-Ras Isoforms: Unique Conformational Preferences and Implications for Targeting Oncogenic Mutants
    Parker, Jillian A.
    Mattos, Carla
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (08):
  • [9] Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients
    Banys-Paluchowski, Malgorzata
    Milde-Langosch, Karin
    Fehm, Tanja
    Witzel, Isabell
    Oliveira-Ferrer, Leticia
    Schmalfeldt, Barbara
    Mueller, Volkmar
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (02) : 403 - 414
  • [10] IMMUNOHISTOCHEMICAL DETECTION OF THE H-RAS, K-RAS, AND N-RAS ONCOGENES IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    MCDONALD, JS
    JONES, H
    PAVELIC, ZP
    PAVELIC, LJ
    STAMBROOK, PJ
    GLUCKMAN, JL
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1994, 23 (08) : 342 - 346